Neurotech hits milestone for retinitis pigmentosa implant
This article was originally published in Clinica
Executive Summary
Representing an important step towards finding a treatment for the degenerative eye disease retinitis pigmentosa, French biotechnology firm Neurotech has started the first human trial of an eye implant designed to treat the condition.